Femme et Homme
- | Pays :
- Netherlands
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to investigate whether in patients with chronic HBeAg-negative hepatitis B, PEG-IFN-ribavirin combination therapy for 1 year leads to enhanced response (HBV DNA <10E4 copies/ml and normal ALT 24 weeks after treatment discontinuation) in comparison with pegylated interferon (PEG-IFN) monotherapy.
Critère d'inclusion
- Hepatitis B